UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Loss of the nuclear receptor corepressor SLIRP compromises male fertility

PloS one, 2013-08, Vol.8 (8), p.e70700-e70700

2013

Volltextzugriff (PDF)

Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region

Biochemical journal, 2010-02, Vol.425 (3), p.575-583

2010

Volltextzugriff (PDF)

ETS1 regulates NKX3.1 5′ promoter activity and expression in prostate cancer cells

The Prostate, 2011-03, Vol.71 (4), p.403-414

2011

Volltextzugriff (PDF)

Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate

Cancer research (Chicago, Ill.), 2005-09, Vol.65 (18), p.8487-8496

2005

Volltextzugriff (PDF)

ETS1 induces transforming growth factor β signaling and promotes epithelial‐to‐mesenchymal transition in prostate cancer cells

Journal of cellular biochemistry, 2019-01, Vol.120 (1), p.848-860

2019

Volltextzugriff (PDF)

Characterization of columnar cell lesions of the breast: immunophenotypic analysis of columnar alteration of lobules with prominent apical snouts and secretions

Human pathology, 2007-02, Vol.38 (2), p.284-292

2007

Volltextzugriff (PDF)

Cover Image, Volume 117, Number 10, October 2016

Journal of cellular biochemistry, 2016-10, Vol.117 (10), p.i-i

2016

Volltextzugriff (PDF)

Activity of ABCG2 Is Regulated by Its Expression and Localization in DHT and Cyclopamine-Treated Breast Cancer Cells

Journal of cellular biochemistry, 2016-10, Vol.117 (10), p.2249-2259

2016

Volltextzugriff (PDF)

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells

Molecular and cellular endocrinology, 1999-08, Vol.154 (1), p.11-20

1999

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor (VEGF) Expression in Prostate Cancer and Benign Prostatic Hyperplasia

The Journal of urology, 1997-06, Vol.157 (6), p.2323-2328

1997

Volltextzugriff (PDF)

Mutations at the Boundary of the Hinge and Ligand Binding Domain of the Androgen Receptor Confer Increased Transactivation Function

Molecular endocrinology (Baltimore, Md.), 2001-01, Vol.15 (1), p.46-56

2001

Volltextzugriff (PDF)

The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides

Biopolymers, 2008, Vol.90 (5), p.595-603

2008

Volltextzugriff (PDF)

Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells

Journal of cellular biochemistry, 2006-12, Vol.99 (5), p.1409-1419

2006

Volltextzugriff (PDF)

Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth

Differentiation (London), 1998-03, Vol.62 (5), p.221-226

1998

Volltextzugriff (PDF)

ERK/MAPK regulation of the androgen responsiveness of breast cancer cells

Advances in experimental medicine and biology, 2008, Vol.617, p.429

2008

Volltextzugriff (PDF)

Differential modulation of cell cycle, apoptosis and PPAR γ2 gene expression by PPAR γ agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells

Prostaglandins, leukotrienes and essential fatty acids, 2006-05, Vol.74 (5), p.283-293

2006

Volltextzugriff (PDF)

Androgen Receptor Expression in Primary Prostate Cancers of Lobund-Wistar Rats and in Tumor-Derived Cell Lines

In vitro cellular & developmental biology. Animal, 1999-11, Vol.35 (10), p.655-662

1999

Volltextzugriff (PDF)

Abstract 4075: Regulation of NKX3.1 by RMND5 proteins

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4075-4075

2013

Volltextzugriff (PDF)

Abstract 1707: Androgen responsiveness of the NKX3.1 gene is regulated by the proto-oncogene ETS1

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1707-1707

2010

Volltextzugriff (PDF)

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence

Clinical cancer research, 1996-02, Vol.2 (2), p.277-285

1996

Volltextzugriff (PDF)

ETSI Regulates NKX3.1 5' Promoter Activity and Expression in Prostate Cancer Cells

The Prostate, 2011, Vol.71 (4), p.403-414

2011

Volltextzugriff (PDF)

Abstract B7: ETS1 overexpression in prostate cancer cells

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4_Supplement), p.B7-B7

2012

Volltextzugriff (PDF)

Regulation of caltrin mRNA expression by androgens in the murine prostate

Journal of andrology, 2001-05, Vol.22 (3), p.449-457

2001

Volltextzugriff (PDF)

Loss of the Nuclear Receptor Corepressor SLIRP Compromises Male Fertility. e70700

PloS one, 2013-08, Vol.8 (8)

2013

Volltextzugriff (PDF)

Murine Progesterone Receptor Expression in Proliferating Mammary Epithelial Cells During Normal Pubertal Development and Adult Estrous Cycle: Association with ERα and ERβ Status

The journal of histochemistry and cytochemistry, 1999-10, Vol.47 (10), p.1323-1330

1999

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Loss of the nuclear receptor corepressor SLIRP compromises male fertility

Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region

ETS1 regulates NKX3.1 5′ promoter activity and expression in prostate cancer cells

Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate

ETS1 induces transforming growth factor β signaling and promotes epithelial‐to‐mesenchymal transition in prostate cancer cells

Characterization of columnar cell lesions of the breast: immunophenotypic analysis of columnar alteration of lobules with prominent apical snouts and secretions

Cover Image, Volume 117, Number 10, October 2016

Activity of ABCG2 Is Regulated by Its Expression and Localization in DHT and Cyclopamine-Treated Breast Cancer Cells

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells

Vascular Endothelial Growth Factor (VEGF) Expression in Prostate Cancer and Benign Prostatic Hyperplasia

Mutations at the Boundary of the Hinge and Ligand Binding Domain of the Androgen Receptor Confer Increased Transactivation Function

The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides

Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells

Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth

ERK/MAPK regulation of the androgen responsiveness of breast cancer cells

Differential modulation of cell cycle, apoptosis and PPAR γ2 gene expression by PPAR γ agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells

Androgen Receptor Expression in Primary Prostate Cancers of Lobund-Wistar Rats and in Tumor-Derived Cell Lines

Abstract 4075: Regulation of NKX3.1 by RMND5 proteins

Abstract 1707: Androgen responsiveness of the NKX3.1 gene is regulated by the proto-oncogene ETS1

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence

ETSI Regulates NKX3.1 5' Promoter Activity and Expression in Prostate Cancer Cells

Abstract B7: ETS1 overexpression in prostate cancer cells

Regulation of caltrin mRNA expression by androgens in the murine prostate

Loss of the Nuclear Receptor Corepressor SLIRP Compromises Male Fertility. e70700

Murine Progesterone Receptor Expression in Proliferating Mammary Epithelial Cells During Normal Pubertal Development and Adult Estrous Cycle: Association with ERα and ERβ Status

Suchergebnisse filtern